Viola Research Group

 

 

                             

                                                                                            


 

 

 

 

People
   Current

   Alumni

 Research Projects
  Amino Acid Biosynthesis

   New Enzymes from Old

   Canavan Disease

   Membrane Proteins

 Publications
   2008       2005         2002

    2007       2004         2001

    2006       2003         2000

                Archives

 
 Facilities
  Instruments

   Photo Tour

 Courses
  Advanced Biochemistry
   Chemistry & Society
   
Spectroscopic Methods
  
Enzymology
   
Bioinorganic Chemistry

 

 News
   Lab News

   Alumni News

 Links
   Other Websites



Copyright © 2003-08
 Viola Research Group

 

Article published Tuesday, March 8, 2005

UT chemist given grant for research



The baby brain in the picture was so distorted, it stopped Ronald Viola cold, drawing him into an article about why this brain went so wrong.

As the biochemist read, he realized he might be in a position to help. Today, you might say it was a picture worth $1 million.

The University of Toledo researcher was recently awarded $1.1 million five-year grant by the National Institutes of Health to study Canavan disease, the rare disease that hurt the infant brain in the magazine photo

 

Canavan disease is so rare, it gets little attention from the research community. An estimated 500 children in the United States have the disease, according to the Canavan Foundation. The malady arises from a defect in a gene that makes an enzyme called aspartoacylase. And therein lies the problem. No one knows much about this enzyme. They can't draw a picture of it. They can't say how it operates, or just why it fails to do its job in children with Canavan.

Photo
Viola

 

 

But Dr. Viola is an enzyme specialist. His laboratory is dedicated to solving their mysteries.

After his magazine revelation, Dr. Viola got right to work, first obtaining a copy of the Canavan-associated gene from another laboratory. During the next two years, his lab figured out how to get the gene into yeast so that it could begin making its enzyme. With the enzyme now available through these yeast cultures, Dr. Viola and his team can finally begin studying it.

When the enzyme is working properly, it helps break down a protein in the brain called N-acetylaspartate or NAA. In Canavan kids, the enzyme is incapable of breaking down NAA. NAA rapidly accumulates, leading to progressive brain damage. Canavan children have a lifespan of 3 to 10 years.



Tell us what you think of the new website.  Email our Webmaster, if you have any comments and/or suggestions on how we can improve this site.